Sunday, January 10, 2010
2009 University of Health Network Toronto Patient Relations report - Office of the (hospital) Ombudsman
This report is of questionable value to patients as the Office of the Ombudsman is not independent but within the institution.
"The Patient Relations Department (Office of the Hospital Ombudsman)"
(repost): Combination therapy: intermittent sorafenib with bevacizumab yields activity and decreased toxicity : BMJ
abstract only - BMJ does not have open access (pay per view/subscription req'd)
Saturday, January 09, 2010
Cancer genetic predisposition: information needs of patients irrespective of risk level.
"Participants were stratified by risk level and included those concerned about an inherited predisposition to breast, ovarian or colorectal cancer."
"Findings indicated that irrespective of a person's actual or perceived level of risk, cancer worry, demographic background or personal motivation; priorities in the type of information required were similar. Greatest emphasis focused on information provision about how risk was assessed. Least important was acquiring an understanding about genes and inheritance patterns. Most participants reported difficulties accessing or finding information."
Improving the Quality of Colorectal Cancer Screening: Assessment of Familial Risk.
"Many patients reporting a known familial cancer syndrome or a very strong family history did not have that history indicated on the endoscopist's procedure form, and recommended follow-up intervals were beyond guideline recommendations for 60.4% of the very high-risk group."
(Texas) Cedar Park woman, fearing high cancer risk, chooses hysterectomy, double mastectomy
plus commentaries from oncologists
Avemar - corporate website
This page shows past research with the pdf files being fully accessible. I haven't looked at the research/quality, so have no comment on this one - anyone?
Current Issue : Menopause
Note: this journal requires a subscription to access the full text of the articles. You can, however, access the abstracts.
Occult fallopian tube carcinoma detected in routine pelvic washing specimens submitted for staging: another justification for pelvic washing cytology?
Diagn Cytopathol. 2009 Dec;
Department of Pathology, University of Michigan, Ann Arbor, Michigan 48109, USA. jjorns@umich.edu
"Peritoneal washing cytology is important in the staging, prognosis, and treatment schema for women diagnosed with gynecologic malignancies. Additionally, peritoneal washings are often performed before the specific diagnosis or even the distinction between benign or malignant lesion is known. Occasionally, the cytology and surgical pathology specimens, although obtained during the same procedure, will show unexpected and/or discordant findings. Perhaps, the greatest dilemma occurs when atypical cells suggestive of malignancy are identified in peritoneal washing specimens when a corresponding benign or discordantly low grade malignant diagnosis is made in the surgical pathology specimen. We present two such cases in which further investigation proved extremely valuable, not only leading to resolution of initially discrepant cytologic and surgical pathology findings but also in the process leading to second diagnoses of early fallopian tube carcinoma. Increasing evidence appears to be pointing to the fallopian tube as the site of origin of many serous carcinomas previously thought to be of primary pelvic or ovarian origin. These cases further confirm the utility of peritoneal washing cytology as a diagnostic modality when routine gross examination and sampling of the surgical specimens alone would have failed to provide the complete diagnosis."
2010 surgical oncology: Lymph node involvement in ovarian serous tumors of low malignant potential: a clinicopathologic study of thirty-six cases.
"Experience with lymph node involvement (LNI) in ovarian serous tumors of low malignant potential (OSLMP) is limited, which has led to an uncertainty about the clinical significance of this phenomenon....."